$1.03
2.83% yesterday
NYSE, Aug 01, 10:00 pm CET
ISIN
US44916K1060
Symbol
HYPR

Hyperfine Stock price

$1.03
+0.34 49.84% 1M
-0.21 16.94% 6M
+0.15 17.05% YTD
-0.13 11.21% 1Y
-0.26 20.16% 3Y
-8.98 89.71% 5Y
-8.98 89.71% 10Y
-8.98 89.71% 20Y
NYSE, Closing price Fri, Aug 01 2025
-0.03 2.83%
ISIN
US44916K1060
Symbol
HYPR

Key metrics

Basic
Market capitalization
$80.2m
Enterprise Value
$47.1m
Net debt
positive
Cash
$33.1m
Shares outstanding
77.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.8 | 5.5
EV/Sales
4.0 | 3.3
EV/FCF
negative
P/B
1.9
Financial Health
Equity Ratio
83.3%
Return on Equity
-83.0%
ROCE
-95.8%
ROIC
-270.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$11.7m | $14.5m
EBITDA
$-42.5m | $-35.2m
EBIT
$-43.5m | $-38.6m
Net Income
$-40.3m | $-37.1m
Free Cash Flow
$-36.2m
Growth (TTM | estimate)
Revenue
0.3% | 12.3%
EBITDA
4.9% | 16.6%
EBIT
4.9% | 10.7%
Net Income
3.9% | 9.0%
Free Cash Flow
13.2%
Margin (TTM | estimate)
Gross
46.2%
EBITDA
-362.3% | -243.3%
EBIT
-370.6%
Net
-343.4% | -255.9%
Free Cash Flow
-308.7%
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
5.2%
Employees
131
Rev per Employee
$100.0k
Show more

Is Hyperfine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Hyperfine Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Hyperfine forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Hyperfine forecast:

Buy
78%
Hold
22%

Financial data from Hyperfine

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12 12
0% 0%
100%
- Direct Costs 6.31 6.31
6% 6%
54%
5.42 5.42
9% 9%
46%
- Selling and Administrative Expenses 27 27
4% 4%
230%
- Research and Development Expense 22 22
3% 3%
187%
-43 -43
5% 5%
-362%
- Depreciation and Amortization 0.98 0.98
8% 8%
8%
EBIT (Operating Income) EBIT -43 -43
5% 5%
-371%
Net Profit -40 -40
4% 4%
-343%

In millions USD.

Don't miss a Thing! We will send you all news about Hyperfine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hyperfine Stock News

Neutral
Business Wire
2 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--First patients enrolled in PRIME study at Yale School of Medicine, aiming to evaluate the potential of AI-powered portable MRI tech in the ED setting.
Neutral
Business Wire
3 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the second quarter 2025 on Wednesday, August 13, 2025. Management will host a corresponding conference ca...
Neutral
Business Wire
5 days ago
TORONTO--(BUSINESS WIRE)--Swoop® AI-powered portable MRI system shows 100% sensitivity for ARIA-E detection in Lecanemab patients (CARE PMR study data presented at AAIC 2025).
More Hyperfine News

Company Profile

Hyperfine, Inc. is a medical device development company, which is engaged in the development of, MRI solutions and non-invasive neural monitoring technology. The company was founded by Jonathan M. Rothberg on February 25, 2014 and is headquartered in Guilford, CT.

Head office United States
CEO Maria Sainz
Employees 131
Founded 2014
Website hyperfine.io

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today